Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Angelucci

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Cancers|April 10, 2019
Targeting Tyrosine Kinases in Cancer: Lessons for an Effective Targeted Therapy in the ClinicAdriano Angelucci
Current Cancer Drug Targets|February 10, 2009
Targeting ERBB receptors to inhibit metastasis: old hopes and new certaintiesAdriano Angelucci
Biomed Research International|June 28, 2014
Prostate cancer and bone: the elective affinitiesNadia Rucci, Adriano Angelucci
Advances in Experimental Medicine and Biology|June 25, 2020
Leptin in Tumor MicroenvironmentAdriano Angelucci, Letizia Clementi, Edoardo Alesse
Diagnostic Pathology|April 15, 2011
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancerAdriano Angelucci, Gianna Pace, Patrizia Sanità, et al.
Biological Chemistry|April 4, 2002
Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activatorsAdriano Angelucci, Claudio Festuccia, Gabriele D'Andrea, et al.
World Journal of Clinical Oncology|August 13, 2014
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsNadia Rucci, Patrizia Sanità, Simona Delle Monache, et al.
International Journal of Molecular Sciences|January 20, 2018
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal CancerAdriano Angelucci, Simona Delle Monache, Alessio Cortellini, et al.
Cancers|June 6, 2020
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned so FarStefano Martellucci, Letizia Clementi, Samantha Sabetta, et al.
Experimental Cell Research|October 10, 2002
Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagementClaudio Festuccia, Adriano Angelucci, Giovanni Gravina, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Cancers|April 10, 2019
Targeting Tyrosine Kinases in Cancer: Lessons for an Effective Targeted Therapy in the ClinicAdriano Angelucci
Current Cancer Drug Targets|February 10, 2009
Targeting ERBB receptors to inhibit metastasis: old hopes and new certaintiesAdriano Angelucci
Biomed Research International|June 28, 2014
Prostate cancer and bone: the elective affinitiesNadia Rucci, Adriano Angelucci
Advances in Experimental Medicine and Biology|June 25, 2020
Leptin in Tumor MicroenvironmentAdriano Angelucci, Letizia Clementi, Edoardo Alesse
Diagnostic Pathology|April 15, 2011
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancerAdriano Angelucci, Gianna Pace, Patrizia Sanità, et al.
Biological Chemistry|April 4, 2002
Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activatorsAdriano Angelucci, Claudio Festuccia, Gabriele D'Andrea, et al.
World Journal of Clinical Oncology|August 13, 2014
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsNadia Rucci, Patrizia Sanità, Simona Delle Monache, et al.
International Journal of Molecular Sciences|January 20, 2018
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal CancerAdriano Angelucci, Simona Delle Monache, Alessio Cortellini, et al.
Cancers|June 6, 2020
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned so FarStefano Martellucci, Letizia Clementi, Samantha Sabetta, et al.
Experimental Cell Research|October 10, 2002
Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagementClaudio Festuccia, Adriano Angelucci, Giovanni Gravina, et al.
Pageof 10